PUBLISHER: The Business Research Company | PRODUCT CODE: 1942615
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942615
Contract sterilization is a service arrangement in which a company or organization outsources its sterilization needs to a specialized third-party provider. This approach is commonly adopted by businesses that need to sterilize medical devices, pharmaceuticals, or other products but lack the in-house capabilities to carry out these processes themselves.
The primary types of contract sterilization include ethylene oxide, gamma irradiation, electron beam, plasma sterilization, and vaporized hydrogen peroxide. Ethylene oxide is a gas utilized in sterilization processes to disinfect medical equipment and materials that cannot endure heat. This category encompasses products that utilize physical, chemical, and mechanical methods, and it is applicable across various sectors, including medical devices, pharmaceuticals, food and beverage, and cosmetics.
Tariffs are influencing the contract sterilization market by increasing costs of imported sterilization equipment, radiation sources, monitoring instruments, and containment systems used in ethylene oxide, gamma, and electron beam services. Medical device and pharmaceutical manufacturers in North America and Europe are most affected due to dependence on specialized imported systems, while Asia-Pacific faces cost pressure on service expansion. These tariffs are increasing service pricing and capital investment requirements. However, they are also driving regional sterilization facility development, localized equipment sourcing, and long-term service capacity expansion.
The contract sterilization market research report is one of a series of new reports from The Business Research Company that provides contract sterilization market statistics, including contract sterilization industry global market size, regional shares, competitors with a contract sterilization market share, detailed contract sterilization market segments, market trends and opportunities, and any further data you may need to thrive in the contract sterilization industry. This contract sterilization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The contract sterilization market size has grown strongly in recent years. It will grow from $5.8 billion in 2025 to $6.35 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to growth in medical device manufacturing, increasing pharmaceutical production volumes, rising regulatory requirements for product sterility, expansion of healthcare infrastructure, adoption of outsourced sterilization models.
The contract sterilization market size is expected to see strong growth in the next few years. It will grow to $9.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for advanced sterilization technologies, rising focus on environmentally friendly sterilization methods, expansion of single-use medical devices, growing investments in biologics and injectables, increasing regulatory scrutiny on sterilization processes. Major trends in the forecast period include increasing outsourcing of sterilization services, rising demand for low-temperature sterilization methods, growing adoption of gamma and electron beam sterilization, expansion of sterilization services for medical devices, enhanced focus on regulatory compliance and validation.
The increasing incidence of hospital-acquired infections (HAIs) is expected to drive growth in the contract sterilization market in the coming years. HAIs are infections acquired by patients during their stay in healthcare facilities, which creates higher demand for sterilization services to minimize infection risks. The rise in HAIs is fueled by growing antibiotic resistance and the increased use of invasive devices such as catheters and ventilators, which provide direct pathways for bacteria. Contract sterilization helps reduce HAIs by thoroughly sterilizing medical devices, surgical instruments, and equipment using standardized, advanced processes. For instance, in May 2024, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, approximately 4.3 million patients in hospitals across the European Union (EU) and European Economic Area (EEA) acquire at least one healthcare-associated infection annually. Therefore, the rising incidence of hospital-acquired infections is propelling the contract sterilization market.
Leading companies in the contract sterilization market are focusing on expanding ethylene oxide (EtO) sterilization capacity through new EtO service lines and upgraded multimodal sterilization sites to meet the growing demand for sterile medical devices and improve process efficiency. Ethylene oxide sterilization is a low-temperature chemical process that uses EtO gas to eliminate microorganisms on heat- or moisture-sensitive medical devices without compromising structural or functional integrity. For example, in July 2023, STERIS Corporation, a U.S.-based provider of medical equipment and sterilization services, launched X-ray sterilization capabilities at its Kuala Ketil, Malaysia facility, complementing its existing gamma and EtO services. The facility operates as a contract sterilization center offering ethylene oxide (EO), gamma, and X-ray sterilization, forming part of STERIS's global sterilization network. It supports medical device manufacturers with routine processing needs, regional APAC capacity expansion, and ISO 13485 compliance.
In December 2023, Allentown LLC, a U.S.-based life science solutions provider, acquired ClorDiSys Solutions, Inc. for an undisclosed amount. This acquisition strengthens Allentown's strategic capabilities by adding advanced decontamination and sterilization technologies, including environmentally friendly solutions, to its service portfolio. It further enhances Allentown's position in the life science and research-support market by improving safety standards and broadening its sterilization offerings for scientific applications. ClorDiSys Solutions, Inc. is a U.S.-based sterilization manufacturer providing contract sterilization services for both FDA-regulated and non-FDA-regulated medical devices.
Major companies operating in the contract sterilization market are Steris Corporation, Sterigenics International LLC, Nelson Labs & Sterigenics, Steripak Limited, Midwest Sterilization Corporation (MSC), Trinity Sterile Inc., Pacific BioLabs Inc., Steritek, E-Beam Services Inc., Andersen Sterilizers Inc., PAMA Manufacturing and Sterilization, Blue Line Sterilization Services, Medistri SA, NovaSterilis, Noxilizer Inc., Prince Sterilization Services LLC, WuXi AppTec Sterilization Services, BGS Beta-Gamma-Service GmbH & Co. KG, Iotron Industries Canada Inc., STERIMED Group
North America was the largest region in the contract sterilization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contract sterilization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the contract sterilization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The contract sterilization market includes revenues earned by entities by providing services such as sterility assurance and monitoring, steam sterilization, gamma radiation sterilization, and consulting and custom solutions. These services are offered on behalf of manufacturers to ensure product sterility. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Contract Sterilization Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses contract sterilization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for contract sterilization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contract sterilization market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.